Open Access
Open access
Frontiers in Pharmacology, volume 14

Advances in the roles of glycyrrhizic acid in cancer therapy

Yuqian Zhang 1
Zixuan Sheng 1
Jing Xiao 1
Yang Li 1
Jie Huang 1
Jinjing Jia 1, 2
Xiansi Zeng 1, 3
Li Li 1, 2
1
 
Research Center of Neuroscience, China
2
 
Department of Physiology, China
3
 
Department of Biochemistry and Molecular Biology, China
Publication typeJournal Article
Publication date2023-08-15
scimago Q1
SJR1.066
CiteScore7.8
Impact factor4.4
ISSN16639812
Pharmacology
Pharmacology (medical)
Abstract

Since the first 70 years of reporting cancer chemotherapy, malignant tumors have been the second most common cause of death in children and adults. Currently, the commonly used anti-cancer methods include surgery, chemotherapy, radiotherapy, and immunotherapy. Although these treatment methods could alleviate cancer, they lead to different forms of side effects and have no particularly significant effect on prolonging the patients’ life span. Glycyrrhizic acid (GL), a native Chinese herbal extract, has a wide range of pharmacological effects, such as anti-cancer, anti-inflammatory, antioxidant, and immune regulation. In this review, the anti-cancer effects and mechanisms of GL are summarized in various cancers. The inhibition of GL on chemotherapy-induced side effects, including hepatotoxicity, nephrotoxicity, genotoxicity, neurotoxicity and pulmonary toxicity, is highlighted. Therefore, GL may be a promising and ideal drug for cancer therapy.

Found 
Found 

Top-30

Journals

1
2
1
2

Publishers

1
2
3
4
5
6
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex
Found error?